In situ Generated (212)Pb-PSMA Ligand in a (224)Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-Positive Cells

Background: New treatments combating bone and extraskeletal metastases are needed for patients with metastatic castration-resistant prostate cancer. The majority of metastases overexpress prostate-specific membrane antigen (PSMA), making it an ideal candidate for targeted radionuclide therapy. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Vilde Y., Juzeniene, Asta, Bruland, Øyvind S., Larsen, Roy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Pediatric
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527546/
https://www.ncbi.nlm.nih.gov/pubmed/32389119
http://dx.doi.org/10.2174/1874471013666200511000532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527546/
https://www.ncbi.nlm.nih.gov/pubmed/32389119
http://dx.doi.org/10.2174/1874471013666200511000532

Ejemplares similares